ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank88
3Y CAGR+72.3%
5Y CAGR+94.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+72.3%/yr
vs +27.3%/yr prior
5Y CAGR
+94.8%/yr
Recent deceleration
Acceleration
+45.1pp
Accelerating
Percentile
P88
Within normal range
vs 5Y Ago
28x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$13.54M-10.0%
2024$15.05M+49.2%
2023$10.08M+281.2%
2022$2.65M+1595.5%
2021$156000.00-67.7%
2020$483000.00-71.4%
2019$1.69M+67.3%
2018$1.01M+96.9%
2017$512000.00-